Momendol (Naproxen)

• Naproxen, delivered via Momendol, is used topically to manage pain and inflammation in musculoskeletal conditions.
• Osteoarthritis (knee): Provides localized pain relief and reduces joint inflammation, improving function for patients with mild to moderate knee OA.
• Acute muscle sprain or strain: Decreases localized swelling and discomfort, facilitating faster recovery after minor soft‑tissue injuries.
• Tendinitis: Alleviates tendon inflammation and pain, supporting continued activity or rehabilitation in affected limbs.
• Bursitis: Reduces inflammation of superficial bursae, easing pain in areas such as the shoulder or hip.
• Post‑operative superficial pain: Offers targeted analgesia at incision sites, helping manage mild to moderate pain after minor surgeries.

• Naproxen exerts its anti‑inflammatory and analgesic effects by reversibly inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes in peripheral tissues. This inhibition decreases the synthesis of prostaglandins, which are mediators of pain, fever, and inflammation. When applied topically, the drug concentrates at the site of application, providing localized reduction of prostaglandin production while limiting systemic exposure. The localized action helps maintain therapeutic effect at the skin and underlying joints.

Topical naproxen may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Skin irritation: Local redness or discomfort at the application site.
• Itching: Mild pruritus that usually resolves with continued use or discontinuation.
• Burning sensation: Transient warmth or stinging upon application.
• Dry skin: Slight flaking or dryness around the treated area.
• Erythema: Redness extending beyond the immediate area of application.

Serious or Rare Side Effects

• Allergic dermatitis: Widespread rash, swelling, or hives indicating hypersensitivity.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis, requiring immediate medical attention.
• Systemic NSAID effects: Gastrointestinal ulceration, bleeding, or renal function changes, especially with extensive use.

When using Momendol, several precautions should be observed to minimize risks and ensure safe application.

• Avoid use on broken or infected skin: Application to compromised skin may increase systemic absorption and cause irritation.
• Limit application area: Do not exceed the recommended surface area (typically not more than 10 cm² per dose) to reduce systemic exposure.
• Monitor for allergic reactions: Discontinue use and seek medical advice if rash, swelling, or severe itching develops.
• Caution in patients with cardiovascular or renal disease: NSAID exposure may exacerbate underlying conditions; consult a healthcare professional.
• Store at room temperature: Keep the product below 25 °C in the original packaging, protected from moisture and direct sunlight.

Topical naproxen can interact with systemic medications, especially when absorbed in significant amounts.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): Increased risk of bleeding due to additive antiplatelet effect.
• Other NSAIDs or COX‑2 inhibitors: Heightened gastrointestinal and renal toxicity.
• Corticosteroids (systemic): Enhanced risk of ulceration and impaired wound healing.
• SSRIs (e.g., sertraline): Combined use may increase bleeding tendency.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: May reduce renal perfusion when combined with NSAIDs.
• Diuretics (loop or thiazide): Potential for decreased renal function and electrolyte imbalance.
• Lithium: NSAIDs can raise lithium levels, requiring serum monitoring.
• Methotrexate: NSAIDs can reduce renal clearance, potentially raising methotrexate levels.